Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-SOCIME 2025 Congress
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
Venezuela Sessions 2025
Costa Rica Sessions 2025
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
2025 SOLACI Research Grant
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
SOLACI-SIAC LM Revascularization Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Update your Info (members)
Related Organizations
Institutional News
Contact
Search
Search
Search
SOLACI Congress
SOLACI & SBHCI 2026
Welcome to SOLACI & SBHCI 2026
Highlights
General Information
Authorities
SOLACI-SOCIME 2025 Certificates
Facebook
Instagram
Linkedin
Twitter
Youtube
Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-SOCIME 2025 Congress
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
Venezuela Sessions 2025
Costa Rica Sessions 2025
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
2025 SOLACI Research Grant
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
SOLACI-SIAC LM Revascularization Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Update your Info (members)
Related Organizations
Institutional News
Contact
Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-SOCIME 2025 Congress
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
Venezuela Sessions 2025
Costa Rica Sessions 2025
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
2025 SOLACI Research Grant
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
SOLACI-SIAC LM Revascularization Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Update your Info (members)
Related Organizations
Institutional News
Contact
Home
File
File
Structural heart disease
Valvular Aortic Valve
Valvular Aortic valve
Pulmonary Valve
Other
Mitral valve
Válvula Aórtica
Other
View Category
Chronic Ischemic cardiopathy
Coronary Perforation in PCI: Associated to Negative Outcomes
Courtesy of Dr. Guillermo Migliaro. Coronary perforation (CP) is a rare but serious complication of percutaneous coronary intervention...
solaci
-
31 August, 2016
Learn More
Antiplatelet
Anticoagulation and PCI: How Long Should Triple Therapy Last?
The aim of this study was to compare clinical outcomes in relation to the duration of triple...
solaci
-
30 August, 2016
Learn More
Chronic Ischemic cardiopathy
A New Indicator to Assess Stenosis Severity
This study looked at the role of fractional myocardial mass (vessel-specific myocardial mass) in the assessment of...
solaci
-
29 August, 2016
Learn More
Acute coronary syndromes
Intracoronary Abciximab reduces events in diabetics during PPCI
Diabetic patients have an increased risk of future cardiovascular events after an ST elevation MI. Administration of...
solaci
-
24 August, 2016
Learn More
Antiplatelet
Ticagrelor: Similar to Aspirin in Patients with Stroke or TIA
Ticagrelor might be a more effective antiplatelet therapy than aspirin for the prevention of recurrent stroke and...
solaci
-
24 August, 2016
Learn More
Coronary disease
ABSORV at Long Term in Daily Practice Lesions
This work reports one year outcomes of the BVS Expand registry. Multiple studies have shown the safety...
solaci
-
24 August, 2016
Learn More
Structural heart disease
SAPIEN 3: Low One-Year-Mortality in High Risk or Inoperable Patients
In the first PARTNER trial (Placement of Aortic Transcatheter Valves), mortality at one year was 24% for...
solaci
-
23 August, 2016
Learn More
Other
Beta-Blockers for Revascularized Patients: To Prescribe or Not?
This study examines predictors and outcomes associated with the prescription of beta-blockers at discharge after a successful...
solaci
-
23 August, 2016
Learn More